Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids

NCT07167251 · clinicaltrials.gov ↗

RECRUITING

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Immune Related Adverse Events
Immune-Mediated Hepatitis
Cancer

Interventions

DRUG: Low-dose corticosteroids for immune-related hepatitis grade 3
DRUG: Low-dose corticosteroids for immune-related hepatitis grade 2

Sponsor

University Hospital, Basel, Switzerland

Collaborators

[object Object]
[object Object]
[object Object]